Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Cue Biopharma Inc., 3 years.
Cue Biopharma Inc.
Director
Palvella Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cue Biopharma Inc. April 13, 202669.0%
-
Cue Biopharma Inc. June 4, 202577.9%
-
Cue Biopharma Inc. June 5, 202465.2%
-
Cue Biopharma Inc. June 7, 202383.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 23, 2023 | Cue Biopharma Inc. | Option exercise | +9,682 | $2.86 | $27,691 |
| Mar 23, 2023 | Cue Biopharma Inc. | Open-market sale | −9,325 | $3.28 | $30,586 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.